![Peter G. Linde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter G. Linde
Företagsledare/Principal på
Walden Biosciences, Inc.
Profil
Peter G.
Linde is currently the Chief Medical Officer at Walden Biosciences, Inc. He previously worked as the Senior Director-Clinical Development at FibroGen, Inc. and as the Vice President-Medical Research at Acceleron Pharma, Inc. From 2020 to 2021, he served as the Chief Medical Officer at Morphic Holding, Inc. Linde received his undergraduate degree from the Massachusetts Institute of Technology.
Aktiva positioner av Peter G. Linde
| Företag | Position | Start |
|---|---|---|
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides renal therapeutics services | Företagsledare/Principal | 2022-10-11 |
Tidigare kända positioner av Peter G. Linde
| Företag | Position | Slut |
|---|---|---|
| MORC HOLD | Teknisk/Vetenskaplig/F&U Direktör | 2021-12-31 |
| KYNTRA BIO, INC. | Företagsledare/Principal | - |
| ACCELERON PHARMA INC. | Företagsledare/Principal | - |
Peter G. Lindes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides renal therapeutics services | Health Services |
